Exosome delivery system with high stability and preparation method thereof
By forming a calcium carbonate or calcium phosphate encapsulation layer on the exosome surface, the problem of poor exosome storage stability is solved, the effect of maintaining biological activity for a long time at room temperature is achieved, and biocompatibility and pH response are provided. Suitable for clinical applications.
Patent Information
- Application Number
- CN202411029197.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-15
AI Technical Summary
The storage stability of exosomes is poor and is easily degraded during storage and transportation due to conditions such as time, temperature and pH, resulting in loss of biological activity. The existing technology lacks effective standardized storage means, especially in clinical applications. Security and stability issues.
By forming an encapsulating layer on the surface of the exosome, using biocompatible materials such as calcium carbonate or calcium phosphate, small grains of CaCO3 or Ca3(PO4)2 are formed to form an encapsulating layer with a thickness ratio of 1:0.8-2.1, improving Stability of exosomes.
It significantly improves the stability of exosomes, so that they can maintain biological activity for a long time at room temperature, avoid changes in particle size, potential and protein content, and the materials used have good biocompatibility and pH responsiveness, which are suitable for clinical applications. .
Smart Images

Figure CN118948800A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biotechnology, and in particular to an exosome delivery system with high stability and a preparation method thereof. Background Art
[0002] Exosomes (Exo) are spherical membrane vesicles secreted by cells outside the cell, that is, a type of extracellular vesicles, containing substances such as proteins, lipids and nucleic acids. Through exosomes, these substances can be transferred from donor cells to recipient cells, thereby transmitting information between cells. Therefore, exosomes are important participants in intercellular communication. At present, exosomes have made good progress in the diagnosis and treatment of lung cancer, colorectal cancer, breast cancer, pancreatic cancer, cardiovascular and other diseases. Some of them have been clinically applied and have a broad application market.
[0003] Although the diverse sources and wide application of exosomes determine their unique application value, their low storage stability has always been a limiting point for the further promotion and application of exosomes. Exo as a drug carrier is a very promising cell-free treatment method, but the stability of isolated and extracted Exo is poor. Since exosomes are membranous structures with complex components and diverse surface proteins, their stability depends largely on the protection of their double-layer membrane structure, so that their contents are not degraded and denatured in the extracellular environment. Therefore, their biological activity is easily affected by external factors and cannot be stored for a long time. In the actual storage and transportation process, due to the limitations of time, temperature and pH conditions, the proteins on the surface of exosomes will degrade and the membranes will fuse with each other, resulting in an increase in the diameter of the exosomes, a decrease in surface charge, and a decrease in protein content, which leads to a decrease in their storage stability.
[0004] To date, there is no recognized standardized storage method for exosomes that can be used in clinical applications. In order to solve the problem of reduced storage stability of exosomes, many methods have been adopted and repeatedly tested. For example, since exosomes are dominated by bioactive molecules such as DNA, RNA, proteins and lipids, some researchers have tried to preserve them at ultra-low temperatures. However, ultra-low temperature storage easily forms ice crystals, which causes mechanical damage to exosomes, resulting in the destruction of protein signaling molecules on the surface of exosomes and the loss of biological functions. Some researchers have also used new methods such as freeze-drying or spray drying during the storage process to try to find the optimal conditions for the preservation of exosomes. However, although the overall effect of such methods is good, the slower freezing rate will cause nanoparticle aggregation, and when freezing, it is necessary not only to pay attention to the initial freeze-drying temperature and freezing rate, but also to control other conditions such as the concentration and dosage of the protective agent, and the operating conditions are relatively strict.
[0005] In addition to the commonly used preservation methods mentioned above, the surface of exosomes is modified to protect the surface proteins of exosomes from degradation and prevent the fusion of membranes, thereby increasing the stability of exosomes. Compared with other physical preservation methods, this type of method improves the stability of exosomes from the perspective of protecting the membrane structure of exosomes. However, this method will introduce foreign macromolecular polymers into exosomes, which will have a certain impact on the human body in subsequent applications, especially in clinical practice. Summary of the invention
[0006] Purpose of the invention: The present invention aims to provide an exosome delivery system with high stability that can improve the storage stability of exosomes. At the same time, the present invention also provides a method for preparing the exosome delivery system with high stability.
[0007] Technical solution: The exosome delivery system with high stability provided by the present invention is an exosome with an encapsulation layer, and the encapsulation layer is formed by a biocompatible material; the biocompatible material is one or more of calcium carbonate or calcium phosphate.
[0008] Furthermore, the thickness ratio of the exosomes to the encapsulation layer is 1:0.8-2.1, preferably, the thickness ratio is 1:1-1.2.
[0009] Furthermore, the exosome delivery system is stored in a PBS solvent; the concentration of the exosome delivery system in the PBS solvent is 0.4-0.6 μg / μL.
[0010] The present invention also provides a method for preparing the above-mentioned exosome delivery system with high stability, comprising the following steps: dissolving the exosomes in a Ca-containing 2+ The mixture is added into sterile water, mixed evenly to obtain a mixed solution, and then carbonate or phosphate is added to the mixed solution, mixed evenly again, and then centrifuged, washed, and the precipitate is collected to obtain an exosome delivery system with high stability.
[0011] Furthermore, the concentration of the exosomes in the mixed solution is 0.4-0.6 μg / μL; the Ca in the mixed solution 2+ The concentration of the carbonate or phosphate in the mixed solution is 2-4 mM, the concentration of the carbonate or phosphate in the mixed solution is 4-8 mM, and the carbonate or phosphate and Ca 2+ The molar ratio is ≥2.
[0012] Furthermore, the carbonate is sodium carbonate, and the phosphate is disodium hydrogen phosphate dodecahydrate.
[0013] Furthermore, the mixing method is: culturing on a shaker at 300-500 rpm for 30-60 min at 25-37° C.; the centrifugation parameters are: centrifugation at 8000-12000 g for 8-10 min; and sterile water is used for washing.
[0014] Principle of the invention: In the present invention, the surface of the exosome Exo membrane contains abundant proteins, which contain a large number of negatively charged groups such as ·OH and ·COOH, so it can adsorb a large number of positively charged Ca 2+ , which provides nucleation sites for the crystallization of CaCO3 or Ca3(PO4)2 on the Exo surface. After the reaction starts, Ca 2+ Combined with negatively charged groups on the surface of Exo membrane. 2+ With the addition of CO3 2- or PO4 3- The loose CaCO3 or Ca3(PO4)2 small crystals are combined and accumulated on the surface of Exo to form Exo@CaCO3 or Exo@Ca3(PO4)2.
[0015] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: (1) The present invention uses Ca 2+ The calcium carbonate and calcium phosphate used in the present invention are mineralized with carbonate or phosphate on the surface of the exosomes to form an encapsulation layer of a certain thickness, which can significantly improve the stability of the exosomes, enable the exosomes to maintain biological activity for a long time at room temperature, and avoid changes in particle size, potential and protein content; (2) The calcium carbonate and calcium phosphate used in the present invention, as one of the components in the organism, have good biocompatibility and good pH responsiveness, and can be better released in the tumor microenvironment to exert a better therapeutic effect; (3) The preparation method adopted by the present invention is simple and controllable, the conditions are mild, and mass production can be carried out. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 Exo marker protein (A), TEM (B) and particle size result diagram (C) in Example 1;
[0017] Figure 2 This is a schematic diagram of the Exo bionic mineralization process in Example 1;
[0018] Figure 3 The particle size (A), TEM (B) and potential diagram (C) of Exo@CaCO3 in Example 1, infrared spectrum analysis diagram of Exo, CaCO3 and Exo@CaCO3 (D), and SDS-PAGE analysis diagram of protein components of Exo, Exo@CaCO3 and Exo@CaCO3 (pH 6.5) (E);
[0019] Figure 4 The temperature and time stability analysis diagram of Exo and Exo@CaCO3 in Example 1;
[0020] Figure 5 This is the freeze-thaw and temperature stability analysis diagram of Exo and Exo@CaCO3 in Example 1. DETAILED DESCRIPTION
[0021] The present invention is further described below in conjunction with specific embodiments and drawings.
[0022] Example 1: The material used for the encapsulation layer is calcium carbonate
[0023] 1. Preparation and characterization of physicochemical properties of Exo
[0024] To collect exosomes secreted by 293T, the medium containing exosomes was replaced with medium without exosomes, incubated for 36-48h, and the cells were passaged at the same time. Exosomes were collected from the culture medium by continuous centrifugation. Briefly, residual cells, cell debris, and apoptotic bodies were removed from the supernatant by gradient centrifugation. Subsequently, the sample was ultracentrifuged at 120000g for 1.5h, the supernatant was removed, the precipitate was collected, washed with PBS, and ultracentrifuged again at 120000g for 1h, the supernatant was removed, and the precipitate was the exosome, which was resuspended with an appropriate amount of PBS. According to the instructions of the kit, the amount of collected exosomes was calculated by measuring the protein concentration using the BCA protein quantification kit-BOX2. The collected exosomes were stored at 4°C for future use.
[0025] Western Blot technology was used to analyze the expression of Exo-specific markers, and HEK293T cells were used as a control. Figure 1 It shows that only Exo cells express the specific membrane protein CD81; HEK293T cells and Exo cells both express the intracellular proteins ALIX and TSG101. Figure 1 (A) in the figure. The structure of Exo was observed by transmission electron microscopy, showing that its structure is mainly a saucer-shaped vesicle type, such as Figure 1 (B) in the figure, and its particle size is mainly around 140nm, such as Figure 1 (C) in the figure is in line with the normal Exo particle size range. All the above results show that Exo has been successfully obtained.
[0026] 2. Preparation of Exo@CaCO3
[0027] Take 100 μL of sample with a concentration of 0.4-0.6 μg / μL (the solvent is Ca 2+ Sterile water), shake at 25-37°C, 300-500 rpm, add Na2CO3 after 30-60 min, shake at 25-37°C, 300-500 rpm, 30-60 min, centrifuge at 8000-12000g for 8-10 min, wash 3 times with sterile water, and collect the precipitate.
[0028] The biomimetic mineralization method was used to induce CaCO3 crystallization on the Exo surface, such as Figure 2As shown in Figure 2, the surface of the Exo membrane is rich in proteins, which contain a large number of negatively charged groups such as ·OH and ·COOH, so it can adsorb a large amount of positively charged Ca 2+ , providing nucleation sites for the crystallization of CaCO3 on the Exo surface. 2+ Combined with negatively charged groups on the surface of Exo membrane. 2+ With CO3 2- The loose CaCO3 small crystals are combined and accumulated on the surface of Exo to form Exo@CaCO3.
[0029] 3. Characterization of the physicochemical properties of Exo@CaCO3
[0030] The prepared Exo@CaCO3 mineralized particles were characterized by super-resolution transmission electron microscopy (TEM). Figure 3 As shown in (B), the surface of the obtained nano-mineralized particles is relatively smooth and has good dispersibility. The electron density of the mineralized shell is high, and it has good contrast even without any dyeing treatment. Its TEM image shows that the mineralized shell evenly wraps the Exo; compared with pure Exo, the formation of the CaCO3 shell increases the particle size of Exo to about 300nm, as shown in Figure 2. Figure 3 (A); At the same time, because the CaCO3 shell shields the protein on the surface of Exo, the potential of Exo@CaCO3 also increases, such as Figure 3 (C) in.
[0031] Further analysis of the composition of Exo@CaCO3 nanoparticles showed that the protein composition of Exo in the particles and infrared spectroscopy data showed that the protein composition of unencapsulated Exo, Exo mineralized particles encapsulated with CaCO3, and mineralized particles lysed in pH 6.5 buffer for 2 hours were compared by SDS-PAGE. The results showed that Exo@CaCO3 had almost no protein bands, because a layer of CaCO3 was coated on the surface of Exo, forming a shielding effect; after lysing in pH 6.5 buffer for 2 hours, the surface CaCO3 was degraded, and the two had almost exactly the same protein bands as the unencapsulated Exo, indicating that the mineralized particles did contain Exo, and the protein components of Exo were not lost during the mineralization process. Figure 3 The characteristic absorption peaks at 500-1000cm and 1200-2000cm in the spectrum come from the bending and stretching vibrations of the CO single bond and the C=O double bond in calcium carbonate; while the characteristic absorption peaks at 1000-1200cm and 2500-3000cm come from the stretching vibration of CH in organic matter, further confirming that the mineralized particles do contain inorganic calcium carbonate and organic matter, such as Figure 3 (D) in.
[0032] 4. Analysis of temperature and time stability of Exo and Exo@CaCO3
[0033] After Exo and Exo@CaCO3 solutions were stored at 25℃, 4℃, -20℃ and -80℃ for 14d, 30d and 60d, respectively, the particle size, potential and total protein content of the samples were measured to evaluate their temperature and storage time stability.
[0034] The temperature and time stability of nanoparticles have a crucial impact on their in vitro preservation. Due to the unstable outer shell structure, Exo is still exposed, and problems such as degradation of Exo surface membrane proteins may occur. Therefore, the temperature and time stability of Exo and Exo@CaCO3 were investigated. Exo and Exo@CaCO3 nanoparticles were added to phosphate buffer, and the changes in particle size, potential and Exo total protein content were observed after 14d, 30d and 60d. Compared with fresh exosomes, the particle size of Exo stored at room temperature and 4°C increased to 365.02nm and 340.68nm, as shown in Figure 2. Figure 4 In (A), the potential rises to -13.72mV and -14.14mV, as shown in Figure 4 (B) This phenomenon may be due to the fusion of membranes between Exo. As the storage time increases, the total protein content of Exo decreases to 0.217 μg / μL and 0.189 μg / μL. Figure 4 (C) in the figure; this result is consistent with the results of previous studies on the changes in the physical and chemical properties of exosomes stored at different temperatures. Compared with the newly coated nanoparticles, the particle size of Exo@CaCO3 decreased with the extension of time, decreasing to 242.18nm and 241.98nm. The fluctuation may be due to the ionization equilibrium of the CaCO3 shell on the surface of Exo@CaCO3 during the test. Figure 4 (D) in; During storage, the potential and total protein content did not change significantly, such as Figure 4 (E) in 4 and (F) in 4. It can be concluded that compared with Exo alone, Exo@CaCO3 has better storage temperature and time stability.
[0035] 5. Freeze-thaw and temperature stability analysis of Exo and Exo@CaCO3
[0036] The Exo and Exo@CaCO3 solutions were frozen and thawed at -20°C and -80°C for 3, 5 and 10 times, respectively. The particle size, potential and total protein content of the samples were measured to evaluate their temperature and storage time stability.
[0037] Freeze-thaw cycles (FTC) are an important indicator that affects the degree of degradation of Exo surface membrane proteins, which directly determines their structural stability and subsequent application. Due to multiple freeze-thaw cycles during subsequent use, Exo exposure may lead to degradation of Exo surface membrane proteins and destruction of the integrity of the Exo membrane structure. Therefore, the freeze-thaw and temperature stability of Exo and Exo@CaCO3 were investigated. Exo and Exo@CaCO3 nanoparticles were added to phosphate buffer and subjected to freeze-thaw cycles for 3, 5, and 10 times to observe changes in particle size, potential, and Exo total protein content. With the increase in the number of freeze-thaw cycles, the particle size of Exo increased to 282.56nm, and the potential also increased to -14.53mV, such as Figure 5 (A); the total protein content decreased to 0.255μg / μL, and -80℃ and -20℃ had the same trend, with significant differences, such as Figure 5 (B) As the number of freeze-thaw cycles increases, Exo@CaCO3 shows better freeze-thaw stability, and the potential, particle size and total protein content do not change significantly, with no significant difference.
[0038] Example 2: Encapsulating material is calcium phosphate
[0039] Exo and CaP@Exo were placed at -20℃ and -80℃ for 1, 3, and 5 freeze-thaw cycles, and analyzed by particle size and zeta potential. The results showed that the lipid membrane of Exo would rupture during the freeze-thaw cycle, and the ruptured lipid membrane would aggregate to form membrane vesicles with larger particle sizes. At the same time, the negatively charged proteins on the surface of the exosome membrane were easily detached or degraded under the influence of shear force during the freeze-thaw process, causing an increase in membrane potential. The CaP-encapsulated Exo has a mineralized protective shell that increases the mechanical strength of the membrane, and its particle size and potential have not changed significantly, effectively improving its stability during freeze-thaw cycles. Therefore, it is concluded that CaP also has a protective effect on Exo, and the CaP shell enhances the stability of the exosome delivery system.
[0040] In summary, biocompatible materials are used to encapsulate the surface of exosomes, including calcium carbonate or calcium phosphate; after sealing, the exosomes can maintain their biological activity for a long time at room temperature, avoiding changes in particle size, potential and protein content. After 60 days of storage at room temperature, the physical and chemical properties of the exosomes did not change significantly, and the exosomes can be stably preserved. The present invention provides a new option for the storage of exosomes, which facilitates the early clinical application of the exosome delivery system.
Claims
1. An exosome delivery system with high stability, characterized in that: The exosome delivery system is an exosome with an encapsulation layer, and the encapsulation layer is formed by a biocompatible material; the biocompatible material is one or more of calcium carbonate or calcium phosphate.
2. The exosome delivery system with high stability according to claim 1, characterized in that: The thickness ratio of the exosomes to the encapsulation layer is 1:0.8-2.
1.
3. The exosome delivery system with high stability according to claim 2, characterized in that: The thickness ratio of the exosomes to the encapsulation layer is 1:1-1.
2.
4. The exosome delivery system with high stability according to claim 1, characterized in that The exosome delivery system was stored in PBS solvent.
5. A method for preparing the exosome delivery system with high stability according to claim 1, characterized in that: The following steps are involved: Solubilize exosomes in Ca-containing 2+ The mixture is added into sterile water, mixed evenly to obtain a mixed solution, and then carbonate or phosphate is added to the mixed solution, mixed evenly again, and then centrifuged, washed, and the precipitate is collected to obtain an exosome delivery system with high stability.
6. The preparation method according to claim 5, characterized in that: The concentration of the exosomes in the mixed solution is 0.4-0.6 μg / μL.
7. The preparation method according to claim 5, characterized in that: The mixed solution contains Ca 2+ The concentration of the carbonate or phosphate in the mixed solution is 2-4 mM, the concentration of the carbonate or phosphate in the mixed solution is 4-8 mM, and the carbonate or phosphate and Ca 2+ The molar ratio is ≥2.
8. The preparation method according to claim 5, characterized in that: The carbonate is sodium carbonate, and the phosphate is disodium hydrogen phosphate dodecahydrate.
9. The preparation method according to claim 5, characterized in that: The mixing method is: incubating at 25-37°C and 300-500 rpm on a shaking table for 30-60 minutes.
10. The preparation method according to claim 5, characterized in that: The centrifugation parameters are: 8000-12000g for 8-10 min; and sterile water is used for washing.
Citation Information
Cited By
Exosome drug delivery system based on calcium phosphate mediation and preparation method
CN119896651A
